In vitro activity of norfloxacin against multi-resistant bacteria.
D000150:Acinetobacter / Q000187:drug effects*; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D001419:Bacteria / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects*; D006801:Humans; D009268:Nalidixic Acid / Q000031:analogs & derivatives* / Q000633:toxicity; D009643:Norfloxacin; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013211:Staphylococcus aureus / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D009268:Nalidixic Acid; D009643:Norfloxacin